NORCROSS, Ga. A global leader in powder-free surgical gloves and skin antisepsis products announced today the formation of Regent Medical Ltd, a company formed to purchase the assets of the Regent Biogel and Hibi business from SSL International plc. The principal ownership of the new company will be held by a private equity fund advised by Apax Partners one of the worlds leading private equity funds.
This transaction will not only give us an excellent foundation for further development of the companys market position and product lines, but it will also provide us with the resources necessary to be an infection control leader in a continually changing global healthcare community, said Stuart Heap, who will lead the new business venture and take responsibility for the global Biogel and Hibi brands.
Regent Medical, provider of Biogel powder-free, latex surgical gloves, Biogel Skinsense powder-free, non-latex surgical gloves and the Hibi range of antiseptic products, is the surgical glove market leader in several global markets. The only major medical glove company with an exclusively powder-free surgical glove line, Regent Medical continues to be a global leader in protection for acute-care facilities, medical facilities and hospital systems around the world.
"As a leading manufacturer and marketer of protection for healthcare workers and patients, Regent Medical will continue to focus on providing the finest surgical gloves and antiseptic skin cleansers available today," said Heap. We have a remarkable product line and a highly competent management team that has excellent prospects for continued profitable growth while maintaining the highest standard of healthcare protection."
SSL will provide transitional services for a period of up to 10 months and will manufacture Hibi products for Regent Medical for a minimum period of two years.
Source: Regent Medical
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.